{"id":"tp-49893","type":"article-newspaper","title":"PacBio Narrows 2026 Revenue Guidance, Reaffirms 2028 Cash-Flow Breakeven Goal","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/49893","datePublished":"2026-11-06T06:15:18.000Z","dateModified":"2026-11-06T06:15:18.000Z","language":"en","abstract":"PacBio expects $175 million to $185 million in year-end cash and lowered its operating expense outlook to $203 million to $207 million.","section":"Business","references":[]}